Business Context and Reporting Period
Kewaunee Scientific Corporation (KEQU) filed a Form 8-K on November 1, 2024, reporting the completion of the acquisition of Nu Aire, Inc. ("Nu Aire") on the same date. The transaction was executed pursuant to a Securities Purchase Agreement with the sellers, primarily the Peters family and associated trusts.
Key Financial Metrics and Transaction Structure
The total aggregate purchase price for Nu Aire was $55,000,000, subject to customary adjustments for debt, cash, transaction expenses, and net working capital. The funding structure is as follows:
- Cash Payment: $32,000,000 paid at closing, funded partially by new debt facilities.
- Seller Notes: $23,000,000 issued as subordinated seller notes.
- Escrow: $1,000,000 of the purchase price held in a working capital escrow account for post-closing true-ups.
Debt Financing: Concurrent with the acquisition, the Company entered into a Loan Agreement with PNC Bank, National Association, comprising:
- Revolving Credit Facility: $20,000,000 committed senior secured line of credit (with an option to increase by $10,000,000).
- Term Loan: $15,000,000 term loan.
- Maturity: Both facilities mature on November 1, 2029.
- Interest Rates: Variable rates based on base rate or SOFR plus applicable margins (50-200 basis points) determined by the senior debt-to-EBITDA ratio.
- Commitment Fee: $52,500 paid at closing.
Seller Note Terms: The $23,000,000 in Seller Notes accrue interest at 8% per annum and mature on the third anniversary of the closing (November 1, 2027). These notes are subordinated to the PNC Loan Agreement and include a security agreement allowing sellers to convert the default amount into common stock upon an Event of Default.
Material Changes and Covenants
The acquisition represents a material expansion of the Company's asset base. The new debt facilities introduce specific financial covenants that the Company must maintain on a consolidated basis:
- Senior Funded Indebtedness to EBITDA: Not more than 2.50 to 1.00.
- Fixed Charge Coverage Ratio: At least 1.20 to 1.00.
The Loan Agreement also includes negative covenants restricting the incurrence of additional indebtedness, granting of security interests to third parties, and certain non-ordinary course transactions.
Outlook, Risks, and Unusual Items
Management Commentary and Integration: William F. Peters, a seller, has entered into an employment agreement to continue serving as President of Nu Aire and will also serve as a Vice President of Kewaunee Scientific Corporation through December 31, 2026.
Risks and Contingencies:
- Default Risks: The Seller Notes contain events of default including non-payment, insolvency, or default under the PNC Loan Agreement. Upon default, sellers have the right to demand issuance of common stock.
- Financial Covenants: Failure to maintain the required debt-to-EBITDA or fixed charge coverage ratios could trigger an event of default under the PNC Loan Agreement.
- Pro Forma Information: The filing states that pro forma financial information and financial statements of the acquired business will be filed in an amendment within 71 days. No current pro forma metrics are provided in this text.
Investor Verification Checklist
- Verify the final purchase price adjustments regarding net working capital, debt, and cash once the escrow true-up is completed.
- Monitor the Company's ability to comply with the new 2.50x senior debt-to-EBITDA and 1.20x fixed charge coverage covenants.
- Review the upcoming 71-day amendment for pro forma financial statements to assess the combined entity's leverage and liquidity.
- Assess the dilution risk associated with the Seller Notes' conversion feature in the event of a default.
- Confirm the utilization of the $20,000,000 revolving credit facility and the drawdown schedule of the $15,000,000 term loan.